Physician profile
Stephen P Raley
NPI 1336111996
$6,221.66
in general payments reported to CMS, 2019-2025
44 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $584 · 2021: $883 · 2022: $1,143 · 2023: $895 · 2024: $990 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,005.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $913.50 | 2021-2025 | |
| Pfizer INC. | $544.24 | 2019-2025 | |
| Lilly USA, LLC | $469.90 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $453.54 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $347.56 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $312.58 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.79 | 2019-2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $271.72 | 2020-2025 | Zoryve, Seglentis, Livalo |
| Allergan, INC. | $250.81 | 2019-2020 | |
| Corium, LLC | $194.42 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $165.35 | 2019-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Sanofi-Aventis U.S. LLC | $163.71 | 2020-2023 | |
| Otsuka America Pharmaceutical, INC. | $163.53 | 2019-2025 | Rexulti |
| Dexcom, INC. | $143.11 | 2021-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $142.40 | 2019-2023 | Myrbetriq |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.